O
WST icon

OppenheimerFunds’s West Pharmaceutical WST Stock Holding History

OppenheimerFunds’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$13.7M Buy
124,242
+13,137
+12% +$1.37M 0.02% 626
2018
Q4 		$10.9M Buy
111,105
+105,823
+2,003% +$11.5M 0.02% 648
2018
Q3 		$652K Sell
5,282
-1,188
-18% -$133K ﹤0.01% 1325
2018
Q2 		$642K Buy
6,470
+1,077
+20% +$99.1K ﹤0.01% 1316
2018
Q1 		$476K Sell
5,393
-148,772
-97% -$13.9M ﹤0.01% 1423
2017
Q4 		$15.2M Buy
154,165
+5,558
+4% +$545K 0.02% 665
2017
Q3 		$14.3M Sell
148,607
-316,950
-68% -$28.7M 0.02% 674
2017
Q2 		$44M Sell
465,557
-44,242
-9% -$4.07M 0.05% 333
2017
Q1 		$41.6M Sell
509,799
-125,665
-20% -$10.5M 0.05% 358
2016
Q4 		$53.9M Buy
635,464
+35,027
+6% +$2.75M 0.07% 294
2016
Q3 		$44.7M Buy
600,437
+168,384
+39% +$13.4M 0.06% 357
2016
Q2 		$32.8M Buy
432,053
+24,246
+6% +$1.76M 0.04% 425
2016
Q1 		$28.3M Buy
407,807
+26,858
+7% +$1.62M 0.04% 457
2015
Q4 		$22.9M Buy
380,949
+47,334
+14% +$2.85M 0.03% 525
2015
Q3 		$18.1M Buy
333,615
+44,250
+15% +$2.58M 0.02% 574
2015
Q2 		$16.8M Buy
289,365
+14,890
+5% +$831K 0.02% 628
2015
Q1 		$16.5M Sell
274,475
-171,980
-39% -$9.17M 0.02% 639
2014
Q4 		$23.8M Sell
446,455
-177,125
-28% -$8.86M 0.03% 547
2014
Q3 		$27.9M Buy
623,580
+92,320
+17% +$3.92M 0.03% 486
2014
Q2 		$22.4M Buy
531,260
+26,770
+5% +$1.15M 0.02% 543
2014
Q1 		$22.2M Buy
504,490
+84,390
+20% +$3.97M 0.03% 547
2013
Q4 		$20.6M Sell
420,100
-341,740
-45% -$16M 0.03% 549
2013
Q3 		$31.4M Buy
+761,840
New +$29.1M 0.02% 599

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

OppenheimerFunds's WST Position: Q1 2019 in Review

OppenheimerFunds increased its West Pharmaceutical (WST) stake by 12% in Q1 2019, buying an estimated $1.37M and bringing the position to 124,242 shares worth $13.7M. The position accounts for 0.02% of the portfolio, ranked #626.

OppenheimerFunds first reported a position in WST in Q3 2013 and has held it in 23 quarters since. The position peaked at $53.9M in Q4 2016. 379 funds tracked by Wall St. Rank hold WST as of Q1 2019.

  • OppenheimerFunds held 124,242 shares of West Pharmaceutical worth $13.7M as of Q1 2019.
  • OppenheimerFunds bought 13,137 West Pharmaceutical shares in Q1 2019, an estimated $1.37M.
  • West Pharmaceutical made up 0.02% of OppenheimerFunds's portfolio in Q1 2019, its #626 holding.
  • OppenheimerFunds first reported a position in West Pharmaceutical in Q3 2013 and has held it in 23 quarters since.
  • OppenheimerFunds's West Pharmaceutical position peaked at $53.9M in Q4 2016.
  • 379 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.